Crimson Publishers Publish With Us Reprints e-Books Video articles


Modern Research in Dentistry

The New Oral Anticoagulants (NOACs) Between Prevention of Systemic Thromboembolism and Bleeding Procedures in the Dental Office: Review of Literature and Case Report

Submission: March 25, 2019 Published: April 23, 2019

DOI: 10.31031/MRD.2019.03.000576

Volume4 Issue1


There is insufficient data on the use of NOACs during bleeding procedures in the dental office versus old oral anticoagulants. The current therapeutic indications are mostly based on the pharmacodynamics or on small cohort studies. Data from the literature has been reviewed in this respect. A 62-year-old patient under treatment with Rivaroxaban complained of transitory pain in the posterior upper-right jaw. The extraction of second upper right molar was performed, followed by the suture of the socket. According to the therapeutic indications and the available literature on the subject, the administration of the anticoagulant was not ceased. In the following days, repeated bleeding episodes were reported in direct correlation with the timing of Rivaroxaban administration and dose reduction was required to stop post-operative bleeding.

Thus, the effect of NOACs could be unpredictable, as shown in the present case report. Therefore, further clinical research on the subject is needed.

Keywords: Anticoagulants; Apixaban; Dabigatran; Dentistry; Edoxaban; Rivaroxaban

Get access to the full text of this article

About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137